Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Parkinsonism & Related Disorders|July 16, 2021
Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson diseaseColin D McKnight, Paula Trujillo, Alexander M Lopez, et al.Human Brain Mapping|November 1, 2017
Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's diseaseKalen Petersen, Nelleke Van Wouwe, Adam Stark, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|February 19, 2019
Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's diseasePaula Trujillo, Nelleke C van Wouwe, Ya-Chen Lin, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 29, 2020
Structural Correlates of the Sensorimotor Cerebellum in Parkinson's Disease and Essential TremorAlexander M Lopez, Paula Trujillo, Adreanna B Hernandez, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 18, 2023
Accentuated Paralimbic and Reduced Mesolimbic D<sub>2/3</sub>-Impulsivity Associations in Parkinson's DiseaseAdam J Stark, Alexander K Song, Kalen J Petersen, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2018
Nigrostriatal and Mesolimbic D<sub>2/3</sub> Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven BehaviorsAdam J Stark, Christopher T Smith, Ya-Chen Lin, et al.Neurology|December 4, 2018
White matter differences between essential tremor and Parkinson diseaseMeher R Juttukonda, Giulia Franco, Dario J Englot, et al.Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
Overcome the Limitation of Phenome-Wide Association Studies (PheWAS): Extension of PheWAS to Efficient and Robust Large-Scale ICD Codes AnalysisYa-Chen Lin, Siwei Zhang, Tess Vessels, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2024
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and ChemotherapyJoel Neal, Nick Pavlakis, Sang-We Kim, et al.Journal of Huntington'S Disease|April 26, 2021
Healthcare Delivery and Huntington's Disease During the Time of COVID-19Anna C Pfalzer, Lisa M Hale, Elizabeth Huitz, et al.Pageof 3